Related Experiment Video
Updated: Jul 16, 2026

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
Published on: April 18, 2015
[Quantifying the inflammatory activity in Crohn's disease using CE dynamic MRI].
1Abteilung Diagnostische Radiologie, Universitätsklinik Ulm. sandra.pauls@medizin.uni-ulm.de
Dynamic contrast-enhanced MRI quantifies bowel wall inflammation in Crohn's disease patients. This imaging technique shows significant correlation with disease activity indices, aiding in assessing local inflammatory activity.
Area of Science:
- Gastroenterology
- Radiology
- Medical Imaging
Background:
- Crohn's disease is a chronic inflammatory bowel disease.
- Accurate assessment of local inflammatory activity is crucial for effective management.
- Dynamic contrast-enhanced MRI (DCE-MRI) offers potential for non-invasive evaluation.
Purpose of the Study:
- To evaluate the efficacy of dynamic contrast-enhanced MRI in assessing local inflammatory activity in patients with Crohn's disease.
- To correlate MRI findings with established disease activity indices.
Main Methods:
- Prospective study involving 13 patients with histologically confirmed Crohn's disease.
- Acquisition of axial and coronal MRI slices using a 1.5 T scanner, including T1, T2, and dynamic T1 sequences post-contrast administration.
- Contrast uptake analysis through semiquantitative scoring and region of interest (ROI) evaluation, correlated with Crohn's Disease Activity Index (CDAI) and Severe Activity Index (SAI).
Main Results:
- Contrast uptake in the intestinal wall was observed with a mean time to uptake of 18.5 seconds and plateau phase onset at 16.1 seconds.
- Maximum contrast enhancement reached 266% of baseline, with a plateau phase observed in all cases.
- Significant correlations were found between maximum contrast uptake, time to plateau phase, and CDAI (r=0.591, p=0.033; r=0.562, p=0.046 respectively).
Conclusions:
- Dynamic contrast-enhanced MRI is a valuable tool for quantifying local bowel wall inflammation in Crohn's disease.
- The method demonstrates significant correlation with disease activity indices, supporting its potential clinical utility.
- Larger studies are recommended to establish DCE-MRI in routine clinical practice for Crohn's disease management.
More Related Videos
06:46Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent
Published on: May 8, 2017
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Related Concept Videos
Magnetic Resonance Imaging
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease